日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A microenvironment-determined risk continuum refines subtyping in meningioma and reveals determinants of machine learning-based tumor classification.

微环境决定的风险连续体细化了脑膜瘤的亚型,并揭示了基于机器学习的肿瘤分类的决定因素。

Maas Sybren L N, Tang Yiheng, Stutheit-Zhao Eric, Rahmanzade Ramin, Blume Christina, Hielscher Thomas, Zettl Ferdinand, Benfatto Salvatore, Calafato Domenico, Sill Martin, Benotmane Jasim Kada, Yabo Yahaya A, Behling Felix, Suwala Abigail, Kardo Helin, Ritter Michael, Peyre Matthieu, Sankowski Roman, Okonechnikov Konstantin, Sievers Philipp, Patel Areeba, Reuss David, Friedrich Mirco J, Stichel Damian, Schrimpf Daniel, Van den Bosch Thierry P P, Beck Katja, Wirsching Hans-Georg, Jungwirth Gerhard, Hanemann C Oliver, Lamszus Katrin, Etminan Nima, Unterberg Andreas, Mawrin Christian, Remke Marc, Ayrault Olivier, Lichter Peter, Reifenberger Guido, Platten Michael, Kacprowski Tim, List Markus, Pauling Josch K, Baumbach Jan, Milde Till, Grossmann Rachel, Ram Zvi, Ratliff Miriam, Mallm Jan-Philipp, Neidert Marian C, Bos Eelke M, Prinz Marco, Weller Michael, Acker Till, Hartmann Felix J, Preusser Matthias, Tabatabai Ghazaleh, Herold-Mende Christel, Krieg Sandro M, Jones David T W, Pfister Stefan M, Wick Wolfgang, Kalamarides Michel, von Deimling Andreas, Heiland Dieter Henrik, Hovestadt Volker, Gerstung Moritz, Schlesner Matthias, Sahm Felix

L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trial.

L-RNA 适配体 CXCL12 抑制剂联合放射疗法和贝伐单抗治疗新诊断的胶质母细胞瘤:I/II 期 GLORIA 试验的扩展。

Giordano Frank A, Layer Julian P, Turiello Roberta, Friker Lea L, Mirallas Oriol, Pregler Barbara E F, Potthoff Anna-Laura, Zeyen Thomas, Weller Johannes, Sperk Elena, Sahm Katharina, Oster Christoph, Kebir Sied, Hambsch Peter, Schäfer Niklas, Kadzik Sebastian, Renovanz Mirjam, Pietsch Torsten, Bisdas Sotirios, Sepúlveda-Sánchez Juan Manuel, Gómez-Puerto Diego, Vieito Maria, Platten Michael, Gkika Eleni, Grauer Oliver M, Tabatabai Ghazaleh, Schneider Matthias, Glas Martin, Seidel Clemens, Herrlinger Ulrich, Hölzel Michael

A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma

基于DNA甲基化建模的颅内脑膜瘤临床管理框架

Landry, Alexander P; Wang, Justin Z; Patil, Vikas; Ajisebutu, Andrew; Gui, Chloe; Yefet, Leeor S; Ellenbogen, Yosef; Liu, Jeff; Mamatjan, Yasin; Wei, Qingxia; Singh, Olivia; Mansouri, Sheila; Ehret, Felix; Capper, David; Cohen-Gadol, Aaron A; Tabatabai, Ghazaleh; Tatagiba, Marcos; Behling, Felix; Barnholtz-Sloan, Jill S; Sloan, Andrew E; Chambless, Lola B; Mansouri, Alireza; Makarenko, Serge; Yip, Stephen; Tsang, Derek S; Gao, Andrew; Aldape, Kenneth; Nassiri, Farshad; Zadeh, Gelareh

Assessment of molecular tools in pediatric, adolescent, and young adult meningioma highlights the need for lifespan precision in neuro-oncology

对儿童、青少年和青年脑膜瘤分子工具的评估凸显了神经肿瘤学中生命周期精准诊断的必要性。

Yefet, Leeor S; Landry, Alexander P; Wang, Justin Z; Liu, Jeff; Patil, Vikas; Gui, Chloe; Ajisebutu, Andrew; Ellenbogen, Yosef; Mamatjan, Yasin; Yakubov, Rebecca; Kaloti, Ramneet; Persaud, Phooja; Wei, Qingxia; Singh, Olivia; Mansouri, Sheila; Bunda, Severa; Cohen-Gadol, Aaron A; Tabatabai, Ghazaleh; Tatagiba, Marcos; Behling, Felix; Barnholtz-Sloan, Jill S; Sloan, Andrew E; Chotai, Silky; Chambless, Lola B; Mansouri, Alireza; Agnihotri, Sameer; Makarenko, Serge; Yip, Stephen; Tsang, Derek S; Aldape, Kenneth; Gao, Andrew; Nassiri, Farshad; Zadeh, Gelareh

High human cytomegalovirus antigen expression in pediatric medulloblastoma tissue is associated with poor event-free survival

儿童髓母细胞瘤组织中人巨细胞病毒抗原高表达与较差的无事件生存期相关。

De la Cerda-Vargas, Maria F; Schittenhelm, Jens; Ebinger, Martin; Zipfel, Julian; Beschorner, Rudi; Tabatabai, Ghazaleh; Schuhmann, Martin U

Clinical outcome of biomarker-guided therapies in adult neuro-oncology patients: An update from the Tübingen molecular tumor board cohort

生物标志物指导治疗在成人神经肿瘤患者中的临床结果:来自蒂宾根分子肿瘤委员会队列的最新进展

Rieger, David; Becker, Hannes; Walter, Bianca; Dörner, Lorenz; Kurz, Sylvia C; Niyazi, Maximilian; Bodensohn, Raphael; Neumann, Manuela; Rieß, Olaf; Schroeder, Christopher; Ballin, Nadja; Ott, Alexander; Roggia, Cristiana; Ossowski, Stephan; Fend, Falko; Singer, Stephan; Nahnsen, Sven; Kohlbacher, Oliver; Ernemann, Ulrike; Sundberg Malek, Holly; Schittenhelm, Jens; Bitzer, Michael; Malek, Nisar; Tatagiba, Marcos; Renovanz, Mirjam; Tabatabai, Ghazaleh

Clinical advancement in the management of mutant isocitrate dehydrogenase (IDH) cancers

突变型异柠檬酸脱氢酶(IDH)癌症治疗的临床进展

Bridgewater, John; Tabatabai, Ghazaleh; Macarulla, Teresa; Stacchiotti, Silvia

Isocitrate dehydrogenase mutations as potential tumour agnostic targets

异柠檬酸脱氢酶突变作为潜在的肿瘤非特异性靶点

Macarulla, Teresa; Tabatabai, Ghazaleh; Stacchiotti, Silvia; Bridgewater, John

Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N(2)M(2) umbrella trial

胶质母细胞瘤分子匹配靶向治疗联合放疗:1/2a期N(2)M(2)伞状试验

Wick, Wolfgang; Lanz, Lisa-Marie; Wick, Antje; Harting, Inga; Dettmer, Susan; Suwala, Abigail K; Ketter, Ralf; Tabatabai, Ghazaleh; Seliger, Corinna; Glas, Martin; Burger, Michael C; Timmer, Marco; Ringel, Florian A; Mildenberger, Iris; Schulz-Schaeffer, Walter J; Winkler, Frank; König, Laila; Herold-Mende, Christel; Eisenmenger, Andreas; Pfister, Stefan M; Renovanz, Mirjam; Bendszus, Martin; Sahm, Felix; Platten, Michael; Kessler, Tobias

Chromosome 1p Loss and 1q Gain for Grading of Meningioma

1p染色体缺失和1q染色体获得在脑膜瘤分级中的应用

Landry, Alexander P; Wang, Justin Z; Patil, Vikas; Liu, Jeff; Gui, Chloe; Ellenbogen, Yosef; Ajisebutu, Andrew; Yefet, Leeor; Wei, Qingxia; Singh, Olivia; Sosa, Julio; Mansouri, Sheila; Cohen-Gadol, Aaron A; Tabatabai, Ghazaleh; Tatagiba, Marcos; Behling, Felix; Barnholtz-Sloan, Jill S; Sloan, Andrew E; Chotai, Silky; Chambless, Lola B; Mansouri, Alireza; Makarenko, Serge; Yip, Stephen; Ehret, Felix; Capper, David; Tsang, Derek S; Moliterno, Jennifer; Gunel, Murat; Wesseling, Pieter; Sahm, Felix; Aldape, Kenneth; Gao, Andrew; Zadeh, Gelareh; Nassiri, Farshad